VERMOX

This brand name is authorized in Canada, Cyprus, Estonia, Ireland, Israel, Lithuania, Malta, Mexico, New Zealand, Poland, Romania, South Africa, UK, United States.

Active ingredients

The drug VERMOX contains one active pharmaceutical ingredient (API):

1	Mebendazole UNII 81G6I5V05I - MEBENDAZOLE
	In vitro and in vivo work suggests that mebendazole blocks the uptake of glucose by adult and larval forms of helminths, in a selective and irreversible manner. Inhibition of glucose uptake appears to lead to endogenous depletion of glycogen stores within the helminth. Lack of glycogen leads to decreased formation of ATP and ultrastructural changes in the cells.
	Read more about Mebendazole

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
VERMOX Tablet	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
P02CA01	Mebendazole	P Antiparasitic products, insecticides and repellents → P02 Anthelmintics → P02C Antinematodal agents → P02CA Benzimidazole derivatives
Discover more medicines within P02CA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
CA	Health Products and Food Branch	00556734
EE	Ravimiamet	1007222, 1781894, 1832486, 1837076
GB	Medicines & Healthcare Products Regulatory Agency	139694, 147546, 147549, 163304, 166803, 166805, 23895, 23912
IE	Health Products Regulatory Authority	64033, 73938
IL	מִשְׂרַד הַבְּרִיאוּת	1432, 4335
LT	Valstybinė vaistų kontrolės tarnyba	1012291, 1051993, 1074444, 1077617, 1077706, 1078744, 1083608, 1084788
MT	Medicines Authority	MA018/01201, MA018/01202, PI908/11801A
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	80029, 84402
NZ	Medicines and Medical Devices Safety Authority	15089, 2310, 2311
PL	Rejestru Produktów Leczniczych	100048506, 100070285, 100292689, 100324627, 100352345
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W11305001
US	FDA, National Drug Code	50458-675, 50580-070
ZA	Health Products Regulatory Authority	34/12/0058, G/12/105, K/12/206, W/12/42